Some (-)-(1S,4R) -4-[2-amino-6-(substituted)-9H-purin-9-yl]-2-cyclopentene-1-methanol derivatives have been considered for semiempirical treatment at the level of AM1 type calculations. Certain theoretical structure-activity ...